Molecular biomarkers hold promise to advance the noninvasive diagnosis of male reproductive
system disorders and facilitate the identification and management of these conditions …

Aptamers are typically selected from libraries of random DNA (or RNA) sequences through
systematic evolution of ligands by exponential enrichment (SELEX), which involves several …

Male fertility problems range from diminished production of sperm, or oligozoospermia, to
nonmeasurable levels of sperm in semen, or azoospermia, which is diagnosed in nearly 2% of …

For men struggling to conceive with their partners, diagnostic tools are limited and often
consist of only a standard semen analysis. This baseline test serves as a crude estimation of …

We coin the term “smart aptamers” aptamers with predefined binding parameters (k on , k off
, K d ) of aptamer−target interaction. Aptamers, in general, are oligonucleotides, which are …

Prostate cancer is the most common malignancy and the second leading cause of cancer-related
deaths in men. One common treatment is androgen-deprivation therapy, which …

Seminal plasma is a promising biological fluid to use for noninvasive clinical diagnostics of
male reproductive system disorders. To verify a list of prospective male infertility biomarkers, …

Prostate cancer is the second leading cause of cancer-related deaths among men in North
America. Almost all prostate cancers begin in an androgen-dependent state, so androgen …

To investigate the quantitative response of energy metabolic pathways in human MCF-7
breast cancer cells to hypoxia, glucose deprivation, and estradiol stimulation, we developed a …

Background Cerebrospinal fluid (CSF) is a proximal fluid which communicates closely with
brain tissue, contains numerous brain-derived proteins and thus represents a promising fluid …